The top global medtech industry dynamics identified by the G-MedTech Research team over the past week, briefly presented in multiple languages.
Mindray acquires 24.61% of Shenzhen, China-based APT Medical, the market leader in cardiac electrophysiology and interventional medical devices, for RMB 6,650 million ($931 million) to become the controlling shareholder.
GE HealthCare supplies a comprehensive range of imaging, ultrasound and patient care solutions to Dr. Sulaiman Al-Habib Medical Services Group (HMG), one of the largest and fastest growing hospital chains in Saudi Arabia with thirteen hospitals and eight medical centers.
Synchron acquires an equity stake in ACQUANDAS, a leading technology provider specializing in high-precision components for the healthcare industry, to strengthen its technology innovation and supply chain for its unique product offerings, starting with brain-computer interfaces.
Boston Scientific receives US FDA approval for the FARAPULSE™ Pulsed Field Ablation (PFA) System, indicated for pulmonary vein isolation in the treatment of drug-refractory, recurrent, symptomatic, paroxysmal atrial fibrillation (AF), providing a unique new alternative to standard thermal ablation therapy.
Edwards Lifesciences receives US FDA approval for the EVOQUE tricuspid valve replacement system for the treatment of tricuspid regurgitation (TR), which will be available in three sizes, all delivered through the same low-profile 28F transfemoral system.
Hologic receives US FDA clearance for the Genius Digital Diagnostics System with the Genius Cervical AI algorithm, the first and only FDA-cleared digital cytology system that combines AI with advanced volumetric imaging technology to help identify precancerous lesions and cervical cancer cells.
Hangzhou, China-based Matridx Biotech closes RMB 100 million ($14 million) Series C financing to advance molecular pathogen diagnostics.
Guangzhou, China-based PVmed closes RMB 90 million ($12.6 million) Series B financing to develop and commercialize PV-iRT, the AI-based intelligent radiotherapy solution.
Synergy Spine Solutions closes $30 million Series A financing led by Amzak Health for the development of Synergy Disc® artificial cervical disc.
Shanghai, China-based SANDT closes RMB 200 million ($28 million) in new financing for the development and commercialization of CT tubes.